Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3138364
Max Phase: Preclinical
Molecular Formula: C30H46N2O5S
Molecular Weight: 546.77
Molecule Type: Small molecule
Associated Items:
ID: ALA3138364
Max Phase: Preclinical
Molecular Formula: C30H46N2O5S
Molecular Weight: 546.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@H](CCC(=O)Nc1ccccc1S(N)(=O)=O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C
Standard InChI: InChI=1S/C30H46N2O5S/c1-18(8-13-28(35)32-25-6-4-5-7-26(25)38(31,36)37)22-11-12-23-21-10-9-19-16-20(33)14-15-29(19,2)24(21)17-27(34)30(22,23)3/h4-7,18-24,27,33-34H,8-17H2,1-3H3,(H,32,35)(H2,31,36,37)/t18-,19-,20-,21+,22-,23+,24+,27+,29+,30-/m1/s1
Standard InChI Key: NZMORNOGUGPPNU-LVKUUBCUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 546.77 | Molecular Weight (Monoisotopic): 546.3127 | AlogP: 4.68 | #Rotatable Bonds: 6 |
Polar Surface Area: 129.72 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.80 | CX Basic pKa: | CX LogP: 3.83 | CX LogD: 3.83 |
Aromatic Rings: 1 | Heavy Atoms: 38 | QED Weighted: 0.41 | Np Likeness Score: 1.20 |
1. Scozzafava A, Supuran CT.. (2002) Carbonic anhydrase inhibitors. Preparation of potent sulfonamides inhibitors incorporating bile acid tails., 12 (12): [PMID:12039560] [10.1016/s0960-894x(02)00252-4] |
Source(1):